Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Genomic landscape of <i>Candidozyma auris</i> in Italy, 2019 to 2025: emerging diversity of clade I sub-lineages associated with inter-facility transmission and cross-border transfers.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same author

A randomized clinical trial to compare moxiFloxAcin veRsus aziTHromycin for the trEatment of MycoplaSma geniTalium: the FARTHEST Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Targeted peri-operative prophylaxis in patients colonized with Carbapenem Resistant Enterobacterales undergoing Liver Transplantation: a multinational cohort study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Clinical Spectrum of Children With Parvovirus B19-Associated Acute Myocarditis.

Circulation·2026
Same author

Comparable 5-Year Survival in People With and Without HIV Following Hepatocellular Carcinoma Diagnosis: A Multicenter Study.

Liver international : official journal of the International Association for the Study of the Liver·2025
Same author

Use of isavuconazole in critically ill patients in intensive care units: a prospective, observational, multicentre, cohort study.

JAC-antimicrobial resistance·2025

相关实验视频

Updated: May 11, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.5K

针对Acinetobacter NDM-1疫情的基于Cefiderocol的治疗方案

Giovanna Travi1, Francesco Peracchi1,2, Marco Merli1

  • 1Division of Infectious Diseases, ASST Grande Ospedale Metropolitano Niguarda, 20162 Milan, Italy.

Antibiotics (Basel, Switzerland)
|August 29, 2024
PubMed
概括
此摘要是机器生成的。

塞菲德罗科尔在治疗抗卡巴因的Acinetobacter baumannii (CRAB) 感染,特别是产生NDM的菌株方面表现有前途,其临床治愈率很高. 然而,整体死亡率仍然很高,这凸显了敏感性测试和感染控制的必要性.

关键词:
在Acinetobacter baumannii复杂的复合体中.没有NDM,没有NDM.塞菲德罗科尔 (Cefiderocol) 是一种科里斯 (Colistin) 是一个古老的城市.

更多相关视频

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.0K
Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

4.6K

相关实验视频

Last Updated: May 11, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.5K
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.0K
Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

4.6K

科学领域:

  • 传染性疾病 传染性疾病
  • 抗微生物耐药性 抗微生物耐药性
  • 临床微生物学 临床微生物学

背景情况:

  • 耐卡巴胺的巴曼尼菌 (CRAB) 构成了严重的治疗挑战.
  • 产生金属β-乳糖酶 (MBL) 的CRAB菌株特别难以治疗.
  • 塞菲德罗科尔是一种新型抗生素,具有针对格拉姆阴性细菌的活性,包括一些耐药菌株.

研究的目的:

  • 描述在NDM-CRAB感染爆发期间使用Cefiderocol治疗的结果.
  • 为了在现实环境中评估 cefiderocol 的临床有效性.
  • 评估 cefiderocol 与 NDM-CRAB 隔离物的体外活性.

主要方法:

  • 追溯NDM-CRAB殖民和/或感染的患者病例系列.
  • 对临床结果的分析,包括临床治愈和死亡率.
  • 在实验室中对使用商业测试的临床分离物进行二醇的敏感性测试.

主要成果:

  • 38名患者被NDM-CRAB殖民和/或感染.
  • 13名患者出现了全身性感染 (VAP和BSI).
  • 到第7天,10名 (83%) 患者实现了临床治愈.
  • 实验室内 cefiderocol 活性与体内有效性没有一致的相关性.
  • 总体死亡率仍然很高,特别是在重病患者中.

结论:

  • 塞菲德罗科尔可能是NDM-CRAB感染的可行治疗选择,特别是当其他选择有限时.
  • 观察到高临床治愈率,但整体死亡率需要谨慎使用.
  • 实施醇敏感性测试和强有力的感染控制措施至关重要.